Agenebio
Feb 25, 2025
Alzheimer’s Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics
Alzheimer’s disease is more than just memory loss—it’s a progressive neurodegenerative disorder that slowly erodes cognition, behavior, and independence. What may begin as occasional forgetfulness or difficulty recalling names can soon escalate into disorientation, personality changes, and an inability to carry out...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
